Somogy County Kaposi Mór Teaching Hospital, Kaposvár, Hungary.
Somogy County Kaposi Mór Teaching Hospital, Kaposvár, Hungary.
Arch Phys Med Rehabil. 2018 Dec;99(12):2478-2484.e1. doi: 10.1016/j.apmr.2018.05.007. Epub 2018 Jun 7.
To determine the effects of a high-intensity exercise therapy using sensorimotor and visual stimuli on nondemented Parkinson disease (PD) patients' clinical symptoms, mobility, and standing balance.
Randomized clinical intervention, using a before-after trial design.
University hospital setting.
A total of 72 PD patients with Hoehn and Yahr stage of 2-3, of whom 64 were randomized, and 55 completed the study.
PD patients were randomly assigned to a no physical intervention control (n=20 of 29 completed, 9 withdrew before baseline testing) or to a high-intensity agility program (15 sessions, 3 weeks, n=35 completed).
Primary outcome was the Movement Disorders Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) motor experiences of daily living (M-EDL). Secondary outcomes were Beck Depression score, Parkinson Disease Questionnaire-39 (PDQ-39), EuroQoL Five-Dimension (EQ5D) Questionnaire visual analog scale, Schwab and England Activities of Daily Living (SE ADL) Scale, timed Up and Go (TUG) test, and 12 measures of static posturography.
The agility program improved MDS-UPDRS M-EDL by 38% compared with the 2% change in control (group by time interaction, P=.001). Only the intervention group improved in PDQ-39 (6.6 points), depression (18%), EQ5D visual analog scale score (15%), the SE ADL Scale score (15%), the TUG test (39%), and in 8 of 12 posturography measures by 42%-55% (all P<.001). The levodopa equivalent dosage did not change.
A high-intensity agility program improved nondemented, stage 2-3 PD patients' clinical symptoms, mobility, and standing balance by functionally meaningful margins at short-term follow-up.
确定使用感觉运动和视觉刺激的高强度运动疗法对非痴呆帕金森病(PD)患者的临床症状、活动能力和站立平衡的影响。
随机临床干预,采用前后试验设计。
大学医院环境。
共纳入 72 例 Hoehn 和 Yahr 分期为 2-3 期的 PD 患者,其中 64 例随机分组,55 例完成研究。
PD 患者随机分为无物理干预对照组(29 例中有 20 例完成,9 例在基线测试前退出)或高强度敏捷计划组(15 次,3 周,35 例完成)。
主要结局指标为运动障碍协会统一帕金森病评定量表(MDS-UPDRS)日常生活活动(M-EDL)部分的运动体验。次要结局指标为贝克抑郁评分、帕金森病问卷-39(PDQ-39)、欧洲五维健康量表(EQ5D)视觉模拟评分、施瓦布和英格兰日常生活活动量表(SE ADL)量表、计时起立行走测试(TUG)和 12 项静态姿势描记术测量。
与对照组 2%的变化相比,敏捷计划使 MDS-UPDRS M-EDL 改善了 38%(组间时间交互作用,P=.001)。只有干预组在 PDQ-39(6.6 分)、抑郁(18%)、EQ5D 视觉模拟评分(15%)、SE ADL 量表评分(15%)、TUG 测试(39%)和 12 项姿势描记术测量中的 8 项(42%-55%)方面有所改善(均 P<.001)。左旋多巴等效剂量未发生变化。
高强度敏捷计划可在短期内显著改善非痴呆、Hoehn 和 Yahr 分期 2-3 期 PD 患者的临床症状、活动能力和站立平衡。